Deutsch English Français

Contact

EP0999840

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0999840

EP0999840 - USE OF A DRAFLAZINE ANALOGUE FOR TREATING PAIN [Right-click to bookmark this link]
Former [2000/20]	USE OF DRAFLAZINE-ANALOGUES FOR TREATING PAIN
	[2002/35]
Status	No opposition filed within time limit Status updated on 05.03.2004 Database last updated on 15.06.2024
Most recent event Tooltip	06.08.2004	Lapse of the patent in a contracting state New state(s): LU	published on 22.09.2004 [2004/39]
Applicant(s)	For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE
	[N/P]
Former [2000/20]	For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutseweg 30 2340 Beerse / BE
Inventor(s)	01 / MEERT, Theo, Frans Janssen Pharmaceutica N.V., Turnhoutseweg 30 B-2340 Beerse / BE
	02 / VAN BELLE, Herman Janssen Pharmaceutica N.V., Turnhoutseweg 30 B-2340 Beerse / BE
	[2000/20]
Application number, filing date	98934969.1	09.06.1998
	[2000/20]
	WO1998EP03664
Priority number, date	EP19970201813	16.06.1997 Original published format: EP 97201813
	[2000/20]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9857643
	Date:	23.12.1998
	Language:	EN
	[1998/51]
	Type:	A1 Application with search report
	No.:	EP0999840
	Date:	17.05.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.12.1998 takes the place of the publication of the European patent application.
	[2000/20]
	Type:	B1 Patent specification
	No.:	EP0999840
	Date:	02.05.2003
	Language:	EN
	[2003/18]
Search report(s)	International search report - published on:	EP	23.12.1998
Classification	IPC:	A61K31/495, C07D241/04, A61P23/00	[2002/35]
	CPC:	C07D295/15 (EP,US); A61K31/495 (KR); A61K31/496 (EP,US); A61P23/00 (EP); A61P25/04 (EP); C07D213/38 (EP,US)
	Former IPC [2000/20]	A61K31/495, C07D241/04
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [2000/20]
Title	German:	VERWENDUNG VON EINEM DRAFLAZIN ANALOG ZUR SCHMERZBEHANDLUNG	[2002/35]
	English:	USE OF A DRAFLAZINE ANALOGUE FOR TREATING PAIN	[2002/35]
	French:	UTILISATION D' UN ANALOGUE DE DRAFLAZINE DANS LE TRAITEMENT DE LA DOULEUR	[2002/35]
	Former [2000/20]	VERWENDUNG VON DRAFLAZIN ANALOGA ZUR SCHMERZBEHANDLUNG
	Former [2000/20]	USE OF DRAFLAZINE-ANALOGUES FOR TREATING PAIN
	Former [2000/20]	UTILISATION D'ANALOGUES DE DRAFLAZINE DANS LE TRAITEMENT DE LA DOULEUR
Entry into regional phase	17.01.2000	National basic fee paid
	17.01.2000	Designation fee(s) paid
	17.01.2000	Examination fee paid
Examination procedure	18.11.1998	Request for preliminary examination filed International Preliminary Examining Authority: EP
	17.01.2000	Examination requested [2000/20]
	06.10.2000	Despatch of a communication from the examining division (Time limit: M04)
	11.06.2001	Reply to a communication from the examining division
	22.08.2001	Despatch of a communication from the examining division (Time limit: M06)
	02.04.2002	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	04.06.2002	Reply to a communication from the examining division
	22.07.2002	Communication of intention to grant the patent
	03.02.2003	Fee for grant paid
	03.02.2003	Fee for publishing/printing paid
Opposition(s)	03.02.2004	No opposition filed within time limit [2004/17]
Request for further processing for:	04.06.2002	Request for further processing filed
	04.06.2002	Full payment received (date of receipt of payment) Request granted
	21.06.2002	Decision despatched
	11.06.2001	Request for further processing filed
	11.06.2001	Full payment received (date of receipt of payment) Request granted
	04.07.2001	Decision despatched
Fees paid	Renewal fee
	30.06.2000	Renewal fee patent year 03
	02.07.2001	Renewal fee patent year 04
	01.07.2002	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	02.05.2003
	FI	02.05.2003
	NL	02.05.2003
	CY	09.06.2003
	IE	09.06.2003
	LU	09.06.2003
	DK	02.08.2003
	GR	02.08.2003
	SE	02.08.2003
	PT	04.08.2003
	[2004/39]
Former [2004/36]	AT	02.05.2003
	FI	02.05.2003
	NL	02.05.2003
	CY	09.06.2003
	IE	09.06.2003
	DK	02.08.2003
	GR	02.08.2003
	SE	02.08.2003
	PT	04.08.2003
Former [2004/29]	AT	02.05.2003
	FI	02.05.2003
	NL	02.05.2003
	IE	09.06.2003
	DK	02.08.2003
	GR	02.08.2003
	SE	02.08.2003
	PT	04.08.2003
Former [2004/23]	AT	02.05.2003
	FI	02.05.2003
	NL	02.05.2003
	DK	02.08.2003
	GR	02.08.2003
	SE	02.08.2003
	PT	04.08.2003
Former [2004/05]	AT	02.05.2003
	FI	02.05.2003
	NL	02.05.2003
	GR	02.08.2003
	SE	02.08.2003
	PT	04.08.2003
Former [2004/03]	AT	02.05.2003
	NL	02.05.2003
	GR	02.08.2003
	SE	02.08.2003
	PT	04.08.2003
Former [2004/02]	NL	02.05.2003
	GR	02.08.2003
	SE	02.08.2003
	PT	04.08.2003
Former [2003/50]	SE	02.08.2003
Cited in	International search	[A]FR2368280 (THERAMEX [FR]) [A] 7 * claims 1-8 *;
		[AD]EP0068544 (JANSSEN PHARMACEUTICA NV [BE]) [AD] 1-10 * claims 1-8 *;
		[A]GB2105988 (ROCADOR SA [ES]) [A] 7 * the whole document *;
		[AD]EP0285219 (JANSSEN PHARMACEUTICA NV [BE]) [AD] 1-10 * claims 1-18 *;
		[AD] - TUERKER M N ET AL, "ANALGESIC ACTION OF LIDOFLAZINE (R 7904)", EUROPEAN JOURNAL OF PHARMACOLOGY, (19700701), vol. 11, no. 1, pages 90 - 95, XP000607992 [AD] 1-10 DOI: http://dx.doi.org/10.1016/0014-2999(70)90258-X
		[AD] - ANDERSEN K ET AL, "NUCLEOSIDE TRANSPORT INHIBITION BY DRAFLAZINE IN UNSTABLE CORONARY DISEASE", EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, (1996), vol. 51, no. 1, pages 7 - 13, XP000608017 [AD] 1-10 DOI: http://dx.doi.org/10.1007/s002280050153
		[AD] - IJZERMAN A P ET AL, "INHIBITION OF NUCLEOSIDE TRANSPORT BY A NEW SERIES OF COMPOUNDS RELATED TO LIDOFLAZINE AND MIOFLAZINE", EUROPEAN JOURNAL OF PHARMACOLOGY. MOLECULAR PHARMACOLOGY SECTION, (1989), vol. 172, no. 3, pages 273 - 281, XP000608013 [AD] 1-10 DOI: http://dx.doi.org/10.1016/0922-4106(89)90057-6

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p